IGC
IGC Pharma, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
No N-PORT holders.
Largest filed tie
0
filed ties
—
No thesis.
IGC Pharma, Inc.
0.18
—
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Geode Capital ManagementGeodeindex-like | $239,229 | 16.89% | −15.72% | |
| 2 | Vanguard Capital ManagementVanguardindex-like | $221,657 | 15.65% | +13.43% | |
| 3 | BlackRockBlackRockindex-like | $191,433 | 13.52% | 0.00% | |
| 4 | AdvisorShares InvestmentsAdvisorShares | $184,547 | 13.03% | new | |
| 5 | Citadel AdvisorsCitadel | $118,950 | 8.40% | new | |
| 6 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $114,080 | 8.06% | +0.85% | |
| 7 | Renaissance TechnologiesRenaissance Technologies | $77,957 | 5.50% | −40.78% | |
| 8 | State StreetState Streetindex-like | $54,617 | 3.86% | 0.00% | |
| 9 | Northern TrustNorthern Trustindex-like | $46,315 | 3.27% | +50.14% | |
| 10 | LawoodLawood | $20,400 | 1.44% | 0.00% | |
| 11 | Goldman Sachs GroupGoldman Sachs | $17,827 | 1.26% | 0.00% | |
| 12 | Jane Street GroupJane Street | $17,030 | 1.20% | new | |
| 13 | Dearborn PartnersDearborn Partners | $15,622 | 1.10% | 0.00% | |
| 14 | BB&TBB&T | $13,237 | 0.93% | +32.73% | |
| 15 | CitigroupCitigroup | $12,524 | 0.88% | new | |
| 16 | Fisher Asset ManagementFisher | $11,804 | 0.83% | 0.00% | |
| 17 | Susquehanna International GroupSusquehanna International | $11,798 | 0.83% | −64.53% | |
| 18 | XTX TopcoXTX Topco | $10,711 | 0.76% | −22.25% | |
| 19 | Morgan StanleyMorgan Stanley | $9,574 | 0.68% | +0.23% | |
| 20 | Commonwealth Equity ServicesCommonwealth Equity Services | $9,070 | 0.64% | −1.48% | |
| 21 | Tower Research Capital LLC (TRC)Tower Research Capital LLC (TRC) | $7,509 | 0.53% | +31.16% | |
| 22 | Vanguard Global AdvisersVanguard Globalindex-like | $4,065 | 0.29% | 0.00% | |
| 23 | Wealthcare Advisory PartnersWealthcare Advisory Partners | $2,720 | 0.19% | 0.00% | |
| 24 | BurnhamBurnham | $1,360 | 0.10% | — | |
| 25 | Geneos Wealth ManagementGeneos Wealth | $810 | 0.06% | 0.00% |
33 managers report $1.4M of IGC Pharma on form 13F for the quarter ended Jun 30 '26. 7 of them hold 80% of it; Geode is largest at 16.89%.
Expected move
No implied move.